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Abstract 
 
L-arginine is a substrate for the synthesis of proteins, nitric oxide (NO), creatine, urea, proline, 
glutamate, polyamines and agmatine. In the central nervous system (CNS), arginine is extracted from 
the blood and exchanged by cells through carriers called cationic amino acid transporters (CAT) and 
belonging to the so-called system y+. In order to better understand the arginine transport in CNS, we 
studied in detail the regional distribution of the cells expressing the CAT2(B) transcript in the adult rat 
brain by non-radioisotopic in situ hybridization. We show that CAT2(B) is expressed in neurons and 
oligodendrocytes throughout the brain, but is not detected in astrocytes. The pattern of localization of 
CAT2(B) in the normal adult rat brain fits closely that of CRT1, a specific creatine transporter. Our 
study demonstrates that the in vivo expression of CAT2(B) differs from the one reported in vitro, 
implying that local cellular interactions should be taken into account in studies of gene regulation of 
the CAT2(B) gene. Our work suggests that CAT2(B) may play a role in case of increased NO 
production as well as arginine or creatine deficiency in the brain. 
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1: Introduction 
 
L-arginine is a substrate for many different pathways, including nitric oxide (NO), creatine, urea, 
ornithine, polyamines, glutamate, proline and agmatine, and is essential for protein synthesis [29]. In 
the central nervous system (CNS), arginine originates from the blood, from protein breakdown or is 
recycled by argininosuccinate synthetase (AS) and lyase (AL) from the citrulline generated by nitric 
oxide synthase (NOS). 
 
Within the brain, specific transporters designated as system y+ catalize the exchange of arginine 
between the different cell types [18]. The system y+ was identified at the blood brain barrier (BBB) 
[27], in primary cultured astrocytes [24], in cultured neurons from neocortex and cerebellum [28], as 
well as in synaptosomes extracted from cortex and cerebellum [1]. System y+ carriers are a family of 
cationic amino acid transporters called CATs [18]. Up to now, five different CAT proteins have 
been identified (see [19] for review): CAT1 is considered to be ubiquitously expressed except in 
liver [15]; CAT2(B) is present in different tissues including brain but absent from liver [17]; CAT2A, 
an alternatively spliced variant of CAT2(B), is liver specific [7]; CAT3 is restricted to brain and 
embryonic mesoderm [9,12]; finally CAT4 is expressed in placenta, testis and at a low level in brain 
[2,25]. CAT1, CAT2(B), CAT3 and CAT4 have been described in whole brain homogenates 
[9,12,15,17,25]. We and others have recently described the precise cellular distribution of CAT1 
and CAT3 in the adult rat brain [5,10]. CAT2(B) was reported to be expressed at very low levels in 
rat primary astrocytes [26]. CAT1, CAT2(B) and CAT3 have high affinities for arginine (apparent 
Km around 100 µM in vitro), whereas the liver specific CAT2A has a much lower affinity (apparent 
Km of 2 to 5 mM). No data have been reported so far on the affinity of CAT4 for arginine.  
 
For assessing the physiological impact of the different CAT proteins on NO production or creatine 
synthesis in CNS, the regulation of their gene expression is probably as relevant, if not more, as the 
affinity of the carriers for arginine in vitro. In order to understand the intercellular trafficking of 
arginine in the CNS from capillaries and their adjacent astrocytes to other glial cells and neurons, 
data on the detailed localization of CAT2(B) in the CNS are needed. Since these are missing, we 
investigated the expression of CAT2(B) mRNA in the adult rat brain. We have used a new 
combination of non-radioisotopic in situ hybridization (ISH) with immunohistochemistry to identify 
the cells expressing CAT2(B), and shown that it is restricted to neurons and oligodendrocytes. 
2: Materials and Methods  
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A specific cDNA fragment for the rat CAT2 ([16]; nt 1289-1834) was obtained by reverse 
transcription coupled to PCR using rat liver total RNA as template, and cloned in the vector pGEM-
3Zf(+) into the HincII site. The resulting plasmid was linearized with HindIII to yield the antisense 
probe, and with XbaI to yield the sense probe. The linearized plasmids were gel-purified and used as 
templates for digoxigenin labelled riboprobe synthesis, using T7- or SP6-RNA polymerases 
(Promega, Madison, WI), as described previously [3,5]. Four female adult Wistar rats (300 g, BRL, 
Basel, Switzerland) were deeply anesthetized (10 mg/rat Ketalar, Parke Davis, USA) and sacrificed 
by decapitation. Their brain was extracted within 2 minutes, immediately embedded in tissue freezing 
medium (Jung, Nussloch, Germany) and frozen in isopentane and dry ice. Brains were kept at -80 
°C until used, then cut and analyzed by non-radioactive ISH using the active-DEPC method as 
described [3,5,6]. The specificity of hybridization was ascertained by the use of a sense probe 
having the same length, GC content and activity of digoxigenin labelling as the corresponding 
antisense probe. In each ISH experiment, a section hybridized with a specific antisense probe was 
always preceded or followed by an adjacent section hybridized with the corresponding sense control 
probe. In each ISH experiment, 3 out of 4 of the antisense ISH stained sections were further 
processed for immunohistochemistry. On these sections, neurons, astrocytes and oligodendrocytes 
were labelled using monoclonal antibodies directed against microtubule associated protein 2 
(MAP2), glial fibrillary acidic protein (GFAP) and myelin basic protein (MBP), as described 
previously [6]. The double stained sections (blue signal for ISH and red signal for 
immunohistochemistry) were mounted in glycerol. Sections were observed and photographed on an 
Olympus BX50 microscope equipped with a DP-10 digital camera (Olympus Opticals, Japan). No 
discrepancies were observed between the four female rats analyzed. Brain structures were identified 
according to Paxinos and Watson [20].  
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3: Results 
 
The CAT2(B) mRNA was found in neurons and oligodendrocytes throughout the brain, but never in 
astrocytes. Its main cellular localization was perinuclear. A semi-quantitative description of CAT2(B) 
mRNA levels in the different brain structures is given in Table 1. The specificity of hybridization was 
ascertained by the absence of signal obtained with the CAT2(B) sense probe (Fig.1g). 
 
In the telencephalon, CAT2(B) was expressed in the neocortex, in pyramidal and non-pyramidal 
neurons (Fig.1a,b; co-labelling with MAP2). CAT2(B) was never detected in astrocytes, including 
those contacting capillary and blood vessel endothelial cells (BBB), as illustrated by a co-labelling 
with GFAP (Fig. 2d,f; arrowheads). In the hippocampus, the CAT2(B) transcript was localized at 
high levels in the CA1 layer and the dentate gyrus (Fig.2c). The CA3, polymorphic and molecular 
layers presented a lower signal. In the corpus callosum, CAT2(B) was located in oligodendrocytes 
as demonstrated by a co-labelling with MBP (Fig.2e). The CAT2(B) mRNA was well expressed in 
the olfactory bulb (Fig.1f) and also located in the putamen, the globus pallidum, the nucleus 
accumbens, the pyriform cortex and its transition towards the amygdala nuclei. Most structures of the 
diencephalon, midbrain, pons and medulla showed the CAT2(B) transcript at a weak level, except 
for the brainstem with higher signals in the vestibular nuclei, the locus coeruleus, the trigeminal nuclei 
and the solitatry tract nucleus. In the cerebellar cortex, CAT2(B) was abundantly expressed in 
neurons of the granular layer (Fig.2a-c). Purkinje cells were positive for CAT2(B) mRNA, but at a 
very low level of detection, as shown by a co-labelling with MAP2 (Fig.2b). Bergmann glial cells 
were negative, as shown by a co-labelling with GFAP (Fig.2c). CAT2(B) was also found in the 
cerebellar neurons of the molecular layer and deep nuclei. The CAT2(B) mRNA was expressed at a 
very low level of detection in the white matter structures of cerebellum, in cells identified as 
oligodendrocytes by a co-labelling with MBP (data not shown). The CAT2(B) transcript was also 
revealed in the choroid plexus (Fig.2a) and the ependymal epithelium (data not shown). 
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4: Discussion 
 
4.1: Expression of the CAT2(B) mRNA in the brain 
Previous reports have described the presence of the CAT2(B) mRNA in total homogenates of the 
rodent brain [17], but without a distinction of its expression among cell types. We show in this study 
that in normal conditions the CAT2(B) mRNA is found both in neurons and oligodendrocytes of the 
whole brain. However, we could never detect its expression in astrocytes, including those contacting 
endothelial cells of capillaries and participating to BBB. As for CAT1, the CAT2(B) mRNA was 
mainly localized in the perinuclear region of the brain cells; this is in contrast with the CAT3 
transcript, which we have also found in the neuronal processes [5]. 
 
A comparison of the cerebral expression of the CAT2(B) mRNA with the previously described 
expression of CAT1 and CAT3 transcripts [5] is given in Table 2. Our studies suggest that the prime 
candidate for basic arginine trafficking between brain cells is CAT1, as it is ubiquitously expressed in 
CNS, including at the BBB [5,40]. CAT2(B) and CAT3 could be more specifically involved in the 
arginine uptake and exchange by neurons and oligodendrocytes (CAT2(B)) and neurons only 
(CAT3) (this study, and [5,10]). 
 
4.2: Arginine uptake and metabolism in brain cells 
The availability and uptake of arginine for the different types of brain cells is a prerequisite for their 
local NO and creatine synthesis. Evidence is growing that depending on the physiological and/or 
pathological conditions to which the CNS is exposed, the y+ system of arginine transport as well as 
the intracellular metabolism and recycling of arginine can be regulated at the molecular level. 
 
Rats injected intraperitoneally with lipopolysaccharide (LPS) present a dose-dependent induction of 
the inductible and endothelial NOS genes in the brain, which is restricted to astrocytes [13]. It was 
also shown that primary rat astrocytes treated by LPS and interferon-g (IFNg) present an induction 
of the CAT2(B) gene, together with an increase of their arginine uptake, an induction of the iNOS 
gene and an increase of their NO synthesis [26]. In the same study, primary neurons did not express 
CAT2(B) in control conditions, and did not induce its expression under LPS and IFNg treatment. 
Neuronal PC12 cells do not express CAT2(B) either constitutively or under IFNg and tumor 
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necrosis factor a (TNFa) treatment, whereas they show an induction of the iNOS gene [31]. As 
CAT2(B) is not expressed in vitro in primary neurons nor in PC12 cells [26,31], the constitutive 
neuronal expression of CAT2 we found in this study indicates that the normal brain differs from the 
conditions to which single cell type cultures are exposed in vitro. The CAT2(B) expression in the 
CNS, with its different cell types, might thus depend on intercellular interactions.  
 
The intracellular recycling of arginine by AS and AL has also been shown to be regulated: LPS and 
IFNg injected into the rat brain induce the AS gene in glial cells [8], whereas TNFa and IFNg 
induce both the AS and AL genes in PC12 cells [31]. In human and mouse, primary or secondary 
defects of urea cycle activity lead to a significant decrease of blood arginine concentration 
[11,14,22,23]. This is also found in portacaval shunted or ammonium chloride-treated rats which 
show, in synaptosomes prepared from different parts of the brain, an increase of arginine uptake in 
parallel with augmented NOS activity [21]. We have recently observed that the CNS expression of 
the arginine recycling genes AS and AL is enhanced in astrocytes under ammonium chloride 
treatment [4]. Thus the arginine transport and metabolism seems affected by increased ammonia. 
 
The arginine transport might also be relevant for the creatine synthesis in CNS. Recent studies 
suggest that in normal conditions the brain might depend on its own creatine synthesis due to the 
absence of a creatine transport system at the BBB [6,30]. In consequence, brain cells synthesizing 
creatine depend on the uptake of arginine from the blood and on its local trafficking between the 
different cell types, and on the CNS expression of the CAT genes. Interestingly, the differential 
pattern of expression of CAT2(B) in the rat brain closely follows the expression of CRT1, a specific 
transporter for creatine (see Table 2, and details in [6]). One might speculate that in the brain the 
expression of CAT2(B) and CRT1 is coordinated, and furthermore that CAT2(B) might be involved 
in the creatine synthesis pathway in the CNS. 
 
In the non-nervous tissues, numerous factors have been reported that regulate the CAT genes at the 
molecular level, including cytokines, growth factors, hormones, LPS or a low protein diet (see 
[18,19] for reviews and references therein).  In the CNS or in cell cultures issued from the nervous 
tissue however, only a few data are available. The CAT1 mRNA is constitutively expressed in 
neuronal PC12 cells as well as in primary neurons and astrocytes. However it is not regulated by 
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LPS, IFNg nor TNFa treatments, nor is CAT3 induced in PC12 cells by TNFa and IFNg [26,31]. 
To date in CNS, the only CAT gene which has a regulated expression appears to be CAT2(B): it is 
inducible in primary astrocytes under a LPS and IFNg treatment [26]. It remains to be shown if the 
induction of CAT2(B) also plays a role in vivo, e.g. under pathological conditions. In particular, it 
could be relevant to test if the brain is able to increase its extraction of arginine from the blood by 
induction of the CAT2(B) gene in conditions of arginine or creatine deficiency. 
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Figure legends: 
 
Figure 1: Expression of the CAT2(B) mRNA in the telencephalon. a-f: ISH antisense staining 
for CAT2(B) (blue signal), co-labelled by immunohistochemistry (red signal) for MAP2 (neurons, 
a,b,c), GFAP (astrocytes, d,f) and MBP (oligodendrocytes, e). g: : ISH sense staining for 
CAT2(B). a,b: Layer V of neocortex (pyramidal neurons: arrowheads , non-pyramidal neurons: 
asterisk). c: Dentate gyrus of hippocampus. d: Blood-brain barrier in neocortex with astrocytes 
(arrowheads) extending their podocytes towards capillaries. e: White matter of corpus callosum 
(oligodendrocytes: arrowhead). f,g: Olfactory bulb. Bar: 50 µm. 
 
Figure 2: Expression of the CAT2(B) mRNA in the cerebellar cortex. a-c: ISH antisense 
staining for CAT2(B) (blue signal), co-labelled by immunohistochemistry (red signal) for MAP2 
(a,b) and GFAP (c). a: Cerebellar cortex with the molecular layer (M), the Purkinje cell layer (P) 
and the granule cell layer (G). Choroidal plexus: asterisk. b,c: Higher magnification of the area 
indicated in panel a, with Purkinje cells (b) and Bergman glia (c) located by arrowheads . Bar: 50 
µm. 
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Table 1: Differential expression of the CAT2(B) mRNA in the adult rat brain. 
 
Telencephalon    Hypothalamus (continuation)  
  Neocortex      Premammillary ventral nucleus + 
    Pyramids of layers III and V ++     Zona incerta + 
    Other neurons +   Preoptic area + 
    Astrocytes -   Pituitary (posterior lobe) + 
  Corpus callosum    
    Oligodendrocytes + Midbrain  
    Astrocytes -   Superior colliculus + 
  Olfactory bulb +++   Inferior colliculus + 
  Anterior olfactory nucleus +   Red nucleus ± 
  Anterior commissure ±   Substantia nigra ± 
  Caudate putamen +   Retrorubral fields ± 
  Amygdala +   
  Island of Calleja ++ Brainstem  
  Nucleus accumbens ++   Pontine nucleus + 
  Pyriform cortex +   Trapezoid body nucleus + 
  Hippocampus    Vestibular nuclei ++ 
    CA1 ++   Tegmental nuclei + 
    CA3 +   Locus coeruleus ++ 
    Dentate gyrus +++   Subcoeruleus nuclei + 
    Polymorphic /  
molecular layers 
+   Reticulate formation + 
  Septal nuclei +   Inferior olive ± 
  Diagonal band +   Trigeminal nuclei ++ 
  Globus pallidum +   Solitary tract nucleus +++ 
    
Diencephalon  Cerebellum  
  Thalamus    Molecular layer + 
    Stria medullaris ±   Purkinje cells + 
    Laterodorsal nucleus +   Bergmann glia - 
    Lateroposterior nucleus +   Granular layer neurons ++++ 
    Lateroventral nucleus +   Cerebellar white matter  
    Ventromedial nucleus +     Oligodendrocytes ± 
    Posterior group nuclei +     Astrocytes - 
    Anterior pretectal nucleus +   Deep nuclei neurons + 
    Reticular nucleus +   
  Hypothalamus  Choroidal plexus + 
    Lateral hypothalamic area + Ependymal / subependymal layers + 
 
-: absent; ±: barely detectable; +: weak expression; ++: moderate expression; +++: strong 
expression; ++++: very strong expression. The semi-quantitative description of CAT2(B) mRNA 
levels is based on ISH only experiments. Levels of transcripts observed by optical microscopy are 
indicated by - and + signs, which do not represent a strict linear measure of mRNA levels. 
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Table 2: Summary expression of CAT1, CAT2(B), CAT3 and CRT1 in the rat brain. 
 
 CAT1 CAT2(B) CAT3 CRT1 
Neurons + + + + 
Oligodendrocytes + + - + 
Astrocytes + - - - 
 
CAT: Cationic amino acid transporter; CRT1: creatine transporter. The expression data for CAT1, 
CAT3 and CRT1 are taken from [5,6]. 
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